Suicide is a tragic outcome. In 2012, the 800,000 deaths due to suicide accounted for 1.4% of deaths worldwide, and suicide was the second leading cause of death among adults aged 15-29 years. 1 Between 2000 and 2012, the global rate of suicide decreased by 21%, 2 but those declines are not uniform globally and may be increasing again in some countries. 3 Suicide attempts are far more common than completed suicides. Suicide has been a particular concern in multiple sclerosis (MS). Over a 2-week period, the reported prevalence of suicidal ideation in an MS cohort was 8.3%. 4 Over a 6-month period, 22.1% of participants reported suicidal thoughts. While the frequency of completed suicide is lower than that of suicidal intent, a recent systematic review noted that multiple studies have reported that rates of completed suicide are substantially higher in MS than in the general population, with rate ratios ranging from 1.6-to 14-fold higher. 5 However, other studies have not identified an increased risk. 5 Therefore, in this issue of Multiple Sclerosis Journal, Kalson-Ray et al. 6 aimed to determine whether persons with MS remain at higher risk of suicide as compared to the general population. Previously, they had assembled a cohort of 27,603 prevalent cases of MS from 15 MS centres in French to study mortality. 7 In this study, after linkage to the French deaths registry, they found that 1569 (5.7%) of these cases had died. An additional 4607 individuals had unknown vital status and were assumed to be alive. Among those who died, the cause of death was unknown for 231 (14.7%), and 47 (3.0%) were known to have committed suicide. This corresponded to a suicide rate of 10.79 per 100,000 person-years (95% confidence interval (CI): 7.71, 13.87). After comparing these findings to age-and sex-specific suicide rates in the French population, the authors reported that the risk of suicide was 40% lower in the MS population than expected (standardized mortality ratio (SMR): 0.6; 95% CI: 0.4, 0.8). Faced with the rather surprising observation of a protective effect of MS against suicide, the authors appropriately performed sensitivity analyses. When they included 36 suspected suicide cases, the suicide rate increased to 18.15 per 100,000 person-years, and there was no longer a statistical difference in the suicide-specific mortality rate between the MS population as compared to expectations for the general population.
Determining absolute suicide rates accurately in any population can be difficult. Suicide is underreported on death certificates, 8 and physicians signing death certificates may lack the information to make a determination of suicide in some situations. One Belgian study compared suicide cases identified from death certificates and judicial files, and based on the variability in the cases identified by the two data sources, reported that 7%-42% of suicides might not be captured. 9 Therefore, the reported suicide rates may be underestimates of the true rates. However, these issues would only threaten the study conclusions regarding relative suicide rates if under-reporting differed between the MS and general populations; this is unlikely to be the case. 8 Nonetheless, other potential limitations may threaten the external and internal validities of the study's findings. The authors included prevalent cases of MS who were registered at the 15 study centres at variable points in their disease course. Only one of the study centres would be considered population-based, inducing a potential selection bias which may threaten the external validity (generalizability) of the findings. In particular, these prevalent cases had to survive and be referred to these centres. Possibly, some individuals with MS committed suicide before they could be registered at the study centre, leading to an underestimated rate of suicide. The authors attempted to address this potential bias by restricting the analysis to two of the MS centres with a longer history of following individuals with MS. That analysis included 8187 cases of MS, of whom 29 were known to have died due to suicide, so that the risk of suicide no longer differed between the MS and general populations (SMR: 1.02; 95% CI: 0.68, 1.46). This suggests that selection biases likely play an important role in their findings. When the authors considered the possibility that a proportion of individuals with an unknown cause of death had died due to suicide, choosing the same proportion as that observed among those with a known cause of death, the risk of suicide was not statistically different between the MS and general populations. Collectively, this suggests that the initial estimate that suicide occurs less often in the MS population than expected is not correct. It remains uncertain whether suicide rates truly do not differ between the MS and general populations given the inability to fully correct for the biases inherent in the study design. Further population-based, prospective studies are needed to address the issue of whether suicide rates differ in the MS population and the general population and whether temporal trends in these rates differ.
Whether the risk of suicide is the same or higher in the MS population or the general population, it remains an outcome that occurs far too often in the MS population. Multiple factors may contribute to the risk of suicide. In the general population, genetic factors, psychiatric disorders and sociocultural factors are all considered to be relevant. 10 In MS, depression is one of the strongest risk factors for suicidal ideation, 11 and depression is two-to threefold more common than in the general population 12 but remains undertreated. 13 Social isolation and other factors are also relevant in MS. 14 Suicide may be prevented, 10 and attention needs to be focused on such efforts. 
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